Hirschsprung disease, associated syndromes, and genetics: A review

Journal of Medical Genetics

Volumn 38, Issue 11, 2001, Pages 729-739

  Amiel, J ^a   Lyonnet, S ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Aganglionic megacolon; Genetics; Hirschsprung disease

Indexed keywords

CHROMOSOME ABERRATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GENETIC ANALYSIS; GENETIC COUNSELING; HIRSCHSPRUNG DISEASE; HUMAN; MECONIUM ILEUS; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYNDROME; WAARDENBURG SYNDROME;

EID: 0034764984     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.38.11.729     Document Type: Review

References (170)

1. Stuhlträgheit neugeborener infolge von dilatation und hypertrophic des colons
2. Myenteric plexuses in congenital megacolon; study of 11 cases
3. Acetylcholinesterase activity in suction biopsies of the rectum in the diagnosis of Hirschsprung's disease
4. Early history of the therapy of Hirschsprung's disease: Facts and personal observations over 50 years
5. A family study of Hirschsprung disease
6. The neurocristopathies; a unifying concept of disease arising in neural crest maldevelopment
7. The genetics of Hirschsprung's disease. Evidence for heterogeneous etiology and a study of sixty-three families
8. An epidemiological study of Hirschsprung's disease
9. Hirschsprung disease: A genetic study
10. Hirschsprung disease in a large birth cohort
11. Spectrum of phenotypes associated with Hirschsprung disease: An evaluation of 239 patients from a single institution
12. An epidemiological study of Hirschsprung disease in a multiracial California population
13. A genetic study of Hirschsprung disease
14. Development of the mammalian enteric nervous system
15. Total colonic aganglionosis (with or without ileal involvement): A review of 27 cases
16. Ultrashort Hirschsprung's disease: Myth or reality
17. Megacolon in adults. Apropos of 76 cases
18. Anorectal manometry during the neonatal period: Its specificity in the diagnosis of Hirschsprung's disease
19. Efficiency of the anorectal manometry for the diagnosis of Hirschsprung's disease in the newborn period
20. Suction biopsy in Hirschsprung's disease
21. Hirschsprung's disease. Technique and results of Soave's operation
22. Hirschsprung's disease - The Duhamel modification
23. Enterocolitis after the surgical treatment of Hirschsprung's disease: Risk factors and financial impact
24. Long-term outcome after Hirschsprung's disease: Patients' perspectives
25. Clinical outcome and long-term quality of life after surgical correction of Hirschsprung's disease
26. Perineal one-stage pull-through for Hirschsprung's disease
27. Total colonic aganglionosis
28. Management and long-term follow-up of infants with total colonic aganglionosis
29. Identity-by-descent and association mapping of a recessive gene for Hirschsprung disease on human chromosome 13q22
30. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease
31. Point nucleotidic changes in both the RET proto-oncogene and the endothelin-B receptor gene in a Hirschsprung disease patient associated with Down syndrome
32. Total colonic aganglionosis associated with interstitial deletion of the long arm of chromosome 10
33. Hirschsprung's disease associated with a deletion of chromosome 10 (q11.2q21.2): A further link with the neurocristopathies?
34. Separation of retinoblastoma and esterase D loci in a patient with sporadic retinoblastoma and del(13)(q14.1q22.3)
35. Interstitial deletion of distal 13q associated with Hirschsprung's disease
36. A case of Hirschsprung disease with a chromosome 13 microdeletion, del(13)(q32.3q33.2): Potential mapping of one disease locus
37. Phenotypic variability of del(2) (q22-q23): Report of a case with a review of the literature
38. Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: Delineation of a new syndrome and identification of a locus at chromosome 2q22-q23
39. Clinical outcomes of four patients with microdeletion in the long arm of chromosome 2
40. Mutations in SIPI, encoding Smad interacting protein-1, cause a form of Hirschsprung disease
41. Multiple endocrine neoplasia type 2 and RET: From neoplasia to neurogenesis
42. Hirschsprung's disease in a family with multiple endocrine neoplasia type 2
43. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene
44. Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease
45. C618R mutation in exon 10 of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease
46. Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting
47. Hirschsprung disease in MEN 2A: Increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation
48. Association of multiple endocrine neoplasia type 2 and Hirschsprung disease
49. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease
50. A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness
51. Heterogeneity in Waardenburg syndrome
52. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease
53. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease
54. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome)
55. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome)
56. SOX10 mutations in patients with Waardenburg-Hirschsprung disease
57. An unusual demyelinating neuropathy in a patient with Waardenburg's syndrome
58. Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain
59. A molecular analysis of the Yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies
60. Autosomal-recessive neural crest syndrome with albinism, black lock, cell migration disorder of the neurocytes of the gut, and deafness: ABCD syndrome
61. Piebaldness with Hirschsprung's disease
62. Piebaldism-Waardenburg syndrome: Histopathologic evidence for a neural crest syndrome
63. Hirschsprung's disease and congenital deafness. Familial association
64. Congenital central hypoventilation syndrome: An update
65. Familial neuroblastoma. Report of a kindred with multiple disorders, including neuroblastomas in four siblings
66. Hirschsprung's disease, Ondine's curse, and neuroblastoma - Manifestations of neurocristopathy
67. Neurocristopathy. The association of Hirschsprung's disease-ganglioneuroma with autonomic nervous system dysfunction in 2 children
68. Congenital central hypoventilation syndrome: Inheritance and relation to sudden infant death syndrome
69. Congenital failure of automatic control of ventilation, gastrointestinal motility and heart rate
70. Ondine-Hirschsprung syndrome (Haddad syndrome). Further delineation in two cases and review of the literature
71. Mutations of the RETGDNF signaling pathway in Ondine's curse
72. Point mutation in exon 12 of the receptor tyrosine kinase proto-oncogene RET in Ondine-Hirschsprung syndrome
73. Endothelin-3 frameshift mutation in congenital central hypoventilation syndrome
74. Coexistent neuroblastoma and Hirschsprung's disease -another manifestation of the neurocristopathy?
75. Multifocal ganglioneuroblastoma coexistent with total colonic aganglionosis
76. Meningomyelocele and Hirschprung disease: Theoretical and clinical significance
77. Familial occurrence of neuroblastoma, von Recklinghausen's neurofibromatosis, Hirschsprung's agangliosis and jaw-winking syndrome
78. Hirschsprung megacolon and cleft palate in two sibs
79. Unknown syndrome: Hirschsprung's disease, microcephaly, and iris coloboma: A new syndrome of defective neuronal migration
80. The syndrome of Hirschsprung disease, microcephaly, unusual face, and mental retardation
81. Hirschsprung disease associated with polydactyly, unilateral renal agenesis, hypertelorism, and congenital deafness: A new autosomal recessive syndrome
82. Hirschsprung's disease associated with congenital heart malformation, broad big toes, and ulnar polydactyly in sibs: A case for fetoscopy
83. Hirschsprung's disease, hypoplastic nails, and minor dysmorphic features: A distinct autosomal recessive syndrome?
84. A new syndrome: Heart defect, laryngeal anomalies, preaxial polydactyly, and colonic aganglionosis in sibs
85. Familial Hirschsprung's disease and type D brachydactyly: A report of four affected males in two generations
86. Macrocephaly, Hirschsprung disease, brachydactyly, vertebral defects, and other minor anomalies
87. Brain anomalies, retardation of mentality and growth, ectodermal dysplasia, skeletal malformations, Hirschsprung disease, ear deformity and deafness, eye hypoplasia, cleft palate, cryptorchidism, and kidney dysplasia/hypoplasia (BRESEK/BRESHECK): New X-linked syndrome?
88. The Kaufman-McKusick syndrome: Another association
89. Mutation of a gene encoding a putative chaperonin causes McKusick-Kaufman syndrome
90. Hypothalamic-pituitary dysfunction and Hirschsprung's disease in the Bardet-Biedl syndrome
91. Situs inversus and Hirschsprung disease: Two uncommon manifestations in Bardet-Biedl syndrome
92. Mutations in MKKS cause Bardet-Biedl syndrome
93. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome
94. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene
95. Hirschsprung disease in a 46,XY phenotypic infant girl with Smith-Lemli-Opitz syndrome
96. Cartilage-hair hypoplasia - Clinical manifestations in 108 Finnish patients
97. Cartilage-hair hypoplasia gene assigned to chromosome 9 by linkage analysis
98. Congenital muscular dystrophy with neurological abnormalities: Association with Hirschsprung disease
99. Multicore myopatty, microcephaly, aganglionosis, and short stature
100. Ichthyosis, deafness, and Hirschsprung's disease
101. X linked recessive inheritance of agenesis of the corpus callosum
102. Hydrocephalus and Hirschsprung's disease in a patient with a mutation of L1CAM
103. Additional anomalies in Hirschsprung's disease: An analysis based on the nationwide survey in Japan
104. Hirschsprung's disease: Associated abnormalities and demography
105. An epidemiological study of Hirschsprung's disease and additional anomalies
106. Hirschsprung-associated congenital anomalies
107. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret
108. Report of two patients with hypertrophic pyloric stenosis and Hirschsprung's disease. Coincident or common etiology?
109. Agenesis of corpus callosum, hypertrophic pyloric stenosis and Hirschsprung disease: Coincidence or common etiology?
110. Ileal atresia with total colonic aganglionosis
111. A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10
112. A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10
113. Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
114. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
115. Mutations of the RET proto-oncogene in Hirschsprung's disease
116. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease
117. Exon structure and flanking intronic sequences of the human RET proto-oncogene
118. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease
119. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease
120. Frequency of RET mutations in long- and short-segment Hirschsprung disease
121. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours
122. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
123. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B
124. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B
125. Loss of function effect of RET mutations causing Hirschsprung disease
126. Molecular heterogeneity of RET loss of function in Hirschsprung's disease
127. Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease
128. A human model for multigenic inheritance: Phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus
129. Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression
130. RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease
131. Renal and neuronal abnormalities in mice lacking GDNE
132. Renal agenesis and the absence of enteric neurons in mice lacking GDNF
133. Defects in enteric innervation and kidney development in mice lacking GDNF
134. GDNF signalling through the Ret receptor tyrosine kinase
135. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF
136. Characterization of a multicomponent receptor for GDNF
137. The GDNF protein family: Gene ablation studies reveal what they really do and how
138. Neurturin, a relative of glial-cell-line-derived neurotrophic factor
139. Persephin, a novel neurotrophic factor related to GDNF and neurturin
140. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex
141. Germline mutations in glial cell llne-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient
142. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease
143. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease
144. GFRalphal is an essential receptor component for GDNF in the developing nervous system and kidney
145. GFR alphal-deficient mice have deficits in the enteric nervous system and kidneys
146. Human GFRA1: Cloning, mapping, genomic structure, and evaluation as a candidate gene for Hirschsprung disease susceptibility
147. Investigation of germline GFRα-1 mutations in Hirschsprung disease
148. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
149. Molecular characterization of endothelin receptors
150. Hirschsprung's disease in a kindred: A possible clue to the genetics of the disease
151. Chromosome 13q deletion with Waardenburg syndrome: Further evidence for a gene involved in neural crest function on 13q
152. Association of 13q deletion and Hirschsprung's disease
153. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
154. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons
155. Endothelin-3 gene mutations in isolated and syndromic Hirschsprung disease
156. Endothelin receptor-mediated signaling in Hirschsprung disease
157. Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease
158. Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschsprung's disease
159. Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population
160. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene
161. A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction
162. Association of megacolon with a new dominant spotting gene (Dom) in the mouse
163. Mutation of the Sry-related Sox10 gene in dominant megacolon, a mouse model for human Hirschsprung disease
164. The Sox10 (Dom) mouse: Modeling the genetic variation of Waardenburg-Shah (WS4) syndrome
165. Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease
166. Transcription factor hierarchy in Waardenburg syndrome: Regulation of MITF expression by SOX10 and PAX3
167. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model
168. Werner's mesomelic dysplasia with ventricular septal defect and Hirschsprung's disease